Chemical Computing Group to Host Drinks Reception at the Industry's Leading Summit on Drug Design

LONDON - Jan. 28, 2014 - PRLog -- The 3 day event will feature 2 days’ worth of presentations from leading pioneers in the drug design arena including; D. E. Shaw Research, Pfizer, Roche, MedImmune, Astex Pharmaceuticals, Bayer HealthCare, Sanofi-Aventis, Novartis, plus an interactive post conference workshop on Fragment based approaches to lead discovery which will be led by Lee Walmsley, Senior Team Lead, Medicinal Chemistry from Vernalis.

Those joining the event will also be able to take part in a networking drinks reception hosted on the end of Day 1 by lead sponsor, Chemical Computing Group which will take place at the Marriott Regents Park Hotel in central London.

The 13th annual event will allow attendees to network with a truly global audience to discuss, debate and share ideas and challenges facing the drug design arena. Key areas to be addressed will include structure based drug design, water applications, fragment based drug design, lead optimisation challenges and molecular design. The conference agenda can be viewed at http://www.smi-online.co.uk/goto/2014drugdesign57.asp (http://www.smi-online.co.uk/goto/2014drugdesign.asp?emref...)

Dr Neil Press, Director GDC from Novartis, who will be speaking on PDE4 inhibitors commented, “The Advances And Progress in Drug Design conference deals with the latest ideas and developments in tackling important and difficult targets for medical intervention. The range of talks, including a focus on fragment based drug discovery, the role of water and new modelling and crystallisation techniques, will be of widespread industry interest. A resurgence of interest in chemically modified proteins and the development of tools for emerging areas such as epigenetics highlights the transformative role that medicinal chemists can have in deconvoluting early biology.”

For those who are interested, a brochure can be downloaded at: http://www.smi-online.co.uk/goto/2014drugdesign57.asp (http://www.smi-online.co.uk/goto/2014drugdesign.asp?emref=P-095EL310000023&amp)

Advances & Progress in Drug Design
17-18 February 2014
Marriott Regents Park Hotel, London UK

About SMi Group

Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries.

We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. We hold events in over 30 major cities throughout the world including London, Paris and Singapore and to date have welcomed over 200,000 participants from 80 countries.

About Chemical Computing Group

Chemical Computing Group (CCG) is a leading supplier of software solutions for Life Sciences. Since its inception in 1994, CCG has been providing state-of-the-art applications for drug discovery to pharmaceutical, biotech and academic researchers. CCG’s products and services are used by biologists, medicinal chemists and computational chemists throughout the world. Chemical Computing Group has a proven track record in scientific innovation, consistently releasing new versions and upgrades for all its products. CCG has a very strong reputation for collaborative scientific support, with offices in both North America and Europe. CCG headquarters are in Montreal, Canada. For more information visit: